OssDsign
Courtagefri handel på Nordnet till sista juni 2027! Har du inget konto på Nordnet så är det verkligen läge att skaffa ett. Just nu får nya kunder courtagefri handel till sista juni 2027. Läs mer om erbjudandet och skapa ditt konto här OssDsign's revenues for the fourth quarter of 2023 are expected to exceed market estimates
According to preliminary and unaudited data, sales of OssDsign Catalyst amounted to SEK 18.8 million during the period of October – November 2023, whereas OssDsign Cranial recorded sales of SEK 6.4 million.
"The continued strong market performance of OssDsign Catalyst means we have already exceeded market expectations after only two months in the quarter and confirms the attractiveness of our recently announced strategy shift to fully focus on the high-margin orthobiologics franchise”, said Morten Henneveld, CEO of OssDsign.
A complete financial statement for the fourth quarter will be presented in the year-end report for 2023, to be published on February 6, 2024.
This disclosure contains information that OssDsign AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 06-12-2023 08:00 CET.
| Datum | 2023-12-06, kl 08:00 |
| Källa | Cision |